Skip Main Navigation Links Jump to Footer
Journal of Molecular BiologyVolume 363, Issue 1, 13 October 2006, Pages 75-97

Directed Evolution of an Anti-prion Protein scFv Fragment to an Affinity of 1 pM and its Structural Interpretation(Article)

  • Luginbühl, B.,
  • Kanyo, Z.,
  • Jones, R.M.,
  • Fletterick, R.J.,
  • Prusiner, S.B.,
  • Cohen, F.E.,
  • Williamson, R.A.,
  • Burton, D.R.,
  • Plückthun, A.
  • View Correspondence (jump link)
  • aBiochemisches Institut, Universität Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland
  • bDepartment of Biochemistry and Biophysics, University of California, San Francisco, CA 94143, United States
  • cSapidyne Instruments Inc., 967 East Park Center Boulevard 445, Boise, ID 83706, United States
  • dInstitute for Neurodegenerative Diseases, University of California, San Francisco, CA 94143, United States
  • eDepartment of Neurology, University of California, San Francisco, CA 94143, United States
  • fDepartment of Immunology, The Scripps Research Institute, La Jolla, CA 92037, United States

Abstract

Bovine spongiform encephalopathy (BSE) is a fatal neurodegenerative prion disease affecting cattle that is transmissible to humans, manifesting as a variant of Creutzfeldt-Jakob disease (vCJD) likely following the consumption of meat contaminated with BSE prions. High-affinity antibodies are a prerequisite for the development of simple, highly sensitive and non-invasive diagnostic tests that are able to detect even small amounts of the disease-associated PrP conformer (PrPSc). We describe here the affinity maturation of a single-chain Fv antibody fragment with a binding affinity of 1 pM to a peptide derived from the unstructured region of bovine PrP (BoPrP (90-105)). This is the tightest peptide-binding antibody reported to date and may find useful application in diagnostics, especially when PrPSc is pretreated by denaturation and/or proteolysis for peptide-like presentation. Several rounds of directed evolution and off-rate selection with ribosome display were performed using an antibody library generated from a single PrP binder with error-prone PCR and DNA-shuffling. As the correct determinations of affinities in this range are not straightforward, competition biosensor techniques and KinExA methods were both applied and compared. Structural interpretation of the affinity improvement was performed based on the crystal structure of the original prion binder in complex with the BoPrP (95-104) peptide by modeling the corresponding mutations. © 2006 Elsevier Ltd. All rights reserved.

Author keywords

antibody engineeringBiacorecrystal structureKinExAprion

Indexed keywords

EMTREE drug terms:prion proteinsingle chain fragment variable antibody
EMTREE medical terms:antibody libraryarticlebinding affinitybiosensorcrystal structuredenaturationDNA shufflingmolecular evolutionmolecular modelmutationpolymerase chain reactionpriority journalprotein degradationprotein structureribosome
MeSH:Amino Acid SequenceAmino Acid SubstitutionBrainBrain ChemistryCrystallography, X-RayDirected Molecular EvolutionHumansImmunoglobulin FragmentsImmunoglobulin Variable RegionMolecular Sequence DataPrionsProtein Binding
Species Index:Bos taurus

Chemicals and CAS Registry Numbers:

single chain fragment variable antibody, 334577-34-3, 334577-38-7;

Immunoglobulin Fragments; Immunoglobulin Variable Region; Prions

  • ISSN: 00222836
  • CODEN: JMOBA
  • Source Type: Journal
  • Original language: English
  • DOI: 10.1016/j.jmb.2006.07.027
  • PubMed ID: 16962610
  • Document Type: Article

  Plückthun, A.; Biochemisches Institut, Universität Zürich, Winterthurerstrasse 190, Switzerland;
© Copyright 2011 Elsevier B.V., All rights reserved. © MEDLINE® is the source for the MeSH terms of this document.

Cited by 66 documents

Adolf-Bryfogle, J. , Kalyuzhniy, O. , Kubitz, M.
RosettaAntibodyDesign (RAbD): A general framework for computational antibody design
(2018) PLoS Computational Biology
Dreier, B. , Plückthun, A.
Rapid selection of high-affinity antibody scfv fragments using ribosome display
(2018) Methods in Molecular Biology
Sneha, S. , Nagare, R.P. , Priya, S.K.
Therapeutic antibodies against cancer stem cells: a promising approach
(2017) Cancer Immunology, Immunotherapy
View details of all 66 citations